|Factor of Interest||Comparison Level||Adjusted HR (95% CI)∗||p Value|
|DM type∗||Type I||0.789 (0.517–1.205)||0.2728|
|HbA1c, mmol/mol†||1.012 (1.008–1.017)||<0.0001|
|HbA1c, %†||1.142 (1.088–1.198)||<0.0001|
|Insulin vs. diet-only||1.196 (0.887–1.613)||0.2406|
|Oral agents vs. diet-only||0.994 (0.744–1.329)||0.9678|
Abbreviations as in Tables 1 and 2.
↵∗ Each model was adjusted for a subset of the following baseline characteristics: diabetes treatment, dm*groupvar (diabetes and treatment group [ticagrelor/clopidogrel] variables) female, inclusion criteria, region, number of vascular beds, Rutherford class at baseline, prior MI, statins, tobacco use, major amputation, minor amputation, age, estimated glomerular filtration rate, ABI, weight.
↵† The HR refers to every 1 mmol/mol increment in HbA1c or every 1% increment in HbA1c, respectively.